Cargando…

Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series

We report a case-series of Ayurvedic treatment in seven COVID-19 positive patients with multiple co-morbidities, categorized as high-risk for poor outcome from SARS-CoV-2 infection. All of them recovered completely from their illness with resolution of symptoms following Ayurvedic treatment. The dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Girija, P.L.T., Sivan, Nithya, Naik, Pallavi, Murugavel, Yamini Agalya, M Ravindranath, Thyyar, CV, Krishnaswami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277097/
https://www.ncbi.nlm.nih.gov/pubmed/34276163
http://dx.doi.org/10.1016/j.jaim.2021.06.006
_version_ 1783722014754734080
author Girija, P.L.T.
Sivan, Nithya
Naik, Pallavi
Murugavel, Yamini Agalya
M Ravindranath, Thyyar
CV, Krishnaswami
author_facet Girija, P.L.T.
Sivan, Nithya
Naik, Pallavi
Murugavel, Yamini Agalya
M Ravindranath, Thyyar
CV, Krishnaswami
author_sort Girija, P.L.T.
collection PubMed
description We report a case-series of Ayurvedic treatment in seven COVID-19 positive patients with multiple co-morbidities, categorized as high-risk for poor outcome from SARS-CoV-2 infection. All of them recovered completely from their illness with resolution of symptoms following Ayurvedic treatment. The data was collected from patients treated during the early months of the COVID-19 pandemic (June 2020 to September 2020) at an out-patient Ayurvedic Clinic, Chennai, India. This is a retrospective case series from among the initial 247 COVID-19 patients out of whom 39% were found to be suffering from co-morbidities. We have chosen seven of these patients who fulfilled the criteria for high-risk category, represented by multiple co-morbidities that included cancer, chronic kidney disease (CKD), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), hypertension, and an elderly person over the age of 90 years. Classical Ayurvedic formulations for COVID -19 were chosen so as to avoid complicating co-morbid conditions and patients were maintained on a modified diet. All these high-risk patients were treated at an out-patient setting. The patients were under home quarantine and self-monitored their progress with daily follow-up over the phone by the treating Ayurvedic physician. The main outcome measure included resolution of symptoms and complete recovery from COVID-19 disease in all patients. This case series demonstrates the scope of Ayurvedic interventions in the management of high-risk COVID-19 patients with severe co-morbidities with successful outcome in an out-patient setting.
format Online
Article
Text
id pubmed-8277097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82770972021-07-14 Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series Girija, P.L.T. Sivan, Nithya Naik, Pallavi Murugavel, Yamini Agalya M Ravindranath, Thyyar CV, Krishnaswami J Ayurveda Integr Med Case Report We report a case-series of Ayurvedic treatment in seven COVID-19 positive patients with multiple co-morbidities, categorized as high-risk for poor outcome from SARS-CoV-2 infection. All of them recovered completely from their illness with resolution of symptoms following Ayurvedic treatment. The data was collected from patients treated during the early months of the COVID-19 pandemic (June 2020 to September 2020) at an out-patient Ayurvedic Clinic, Chennai, India. This is a retrospective case series from among the initial 247 COVID-19 patients out of whom 39% were found to be suffering from co-morbidities. We have chosen seven of these patients who fulfilled the criteria for high-risk category, represented by multiple co-morbidities that included cancer, chronic kidney disease (CKD), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), hypertension, and an elderly person over the age of 90 years. Classical Ayurvedic formulations for COVID -19 were chosen so as to avoid complicating co-morbid conditions and patients were maintained on a modified diet. All these high-risk patients were treated at an out-patient setting. The patients were under home quarantine and self-monitored their progress with daily follow-up over the phone by the treating Ayurvedic physician. The main outcome measure included resolution of symptoms and complete recovery from COVID-19 disease in all patients. This case series demonstrates the scope of Ayurvedic interventions in the management of high-risk COVID-19 patients with severe co-morbidities with successful outcome in an out-patient setting. Elsevier 2022 2021-06-17 /pmc/articles/PMC8277097/ /pubmed/34276163 http://dx.doi.org/10.1016/j.jaim.2021.06.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Girija, P.L.T.
Sivan, Nithya
Naik, Pallavi
Murugavel, Yamini Agalya
M Ravindranath, Thyyar
CV, Krishnaswami
Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title_full Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title_fullStr Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title_full_unstemmed Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title_short Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple co-morbidities: A case series
title_sort standalone ayurvedic treatment of high-risk covid-19 patients with multiple co-morbidities: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277097/
https://www.ncbi.nlm.nih.gov/pubmed/34276163
http://dx.doi.org/10.1016/j.jaim.2021.06.006
work_keys_str_mv AT girijaplt standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries
AT sivannithya standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries
AT naikpallavi standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries
AT murugavelyaminiagalya standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries
AT mravindranaththyyar standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries
AT cvkrishnaswami standaloneayurvedictreatmentofhighriskcovid19patientswithmultiplecomorbiditiesacaseseries